{"id":"https://openalex.org/W85605362","doi":"https://doi.org/10.1016/s0027-9684(15)30179-6","title":"Assessing Darunavir/Ritonavir\u2014Based Therapy in a Racially Diverse Population: 48-Week Outcomes From GRACE","display_name":"Assessing Darunavir/Ritonavir\u2014Based Therapy in a Racially Diverse Population: 48-Week Outcomes From GRACE","publication_year":2012,"publication_date":"2012-07-01","ids":{"openalex":"https://openalex.org/W85605362","doi":"https://doi.org/10.1016/s0027-9684(15)30179-6","mag":"85605362","pmid":"https://pubmed.ncbi.nlm.nih.gov/23092052"},"language":"en","primary_location":{"id":"doi:10.1016/s0027-9684(15)30179-6","doi":"https://doi.org/10.1016/s0027-9684(15)30179-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0027-9684(15)30179-6","pdf_url":null,"source":{"id":"https://openalex.org/S4210222641","display_name":"Journal of the National Medical Association","issn_l":"0027-9684","issn":["0027-9684","1943-4693"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Medical Association","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5103094377","display_name":"Kimberly Y. Smith","orcid":"https://orcid.org/0000-0003-1666-6395","observed_orcids":["https://orcid.org/0000-0003-1666-6395"]},"institutions":[{"id":"https://openalex.org/I1285301757","display_name":"Rush University Medical Center","ror":"https://ror.org/01j7c0b24","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1285301757"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kimberly Y. Smith","raw_affiliation_strings":["Rush University Medical Center, Department of Medicine, Section of Infectious Diseases, 600 S. Pauline, Suite 143 acfac, Chicago, IL 60612, USA. kimberly_y_smith@rush.edu","Department of Medicine, Section of Infectious Diseases, Rush University Medical Center, Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rush University Medical Center, Department of Medicine, Section of Infectious Diseases, 600 S. Pauline, Suite 143 acfac, Chicago, IL 60612, USA. kimberly_y_smith@rush.edu","institution_ids":["https://openalex.org/I1285301757"]},{"raw_affiliation_string":"Department of Medicine, Section of Infectious Diseases, Rush University Medical Center, Chicago, Illinois","institution_ids":["https://openalex.org/I1285301757"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017975467","display_name":"Fernando Garc\u00eda","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fernando Garcia","raw_affiliation_strings":["Valley AIDS Council, Harlingen, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Valley AIDS Council, Harlingen, Texas","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083402039","display_name":"Princy N. Kumar","orcid":"https://orcid.org/0000-0002-5994-2727","observed_orcids":["https://orcid.org/0000-0002-5994-2727"]},"institutions":[{"id":"https://openalex.org/I184565670","display_name":"Georgetown University","ror":"https://ror.org/05vzafd60","country_code":"US","type":"education","lineage":["https://openalex.org/I184565670"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Princy Kumar","raw_affiliation_strings":["Department of Medicine, School of Medicine, Georgetown University, Washington, Columbia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, School of Medicine, Georgetown University, Washington, Columbia","institution_ids":["https://openalex.org/I184565670"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084353681","display_name":"Judith S. Currier","orcid":"https://orcid.org/0000-0003-4279-4737","observed_orcids":["https://orcid.org/0000-0003-4279-4737"]},"institutions":[{"id":"https://openalex.org/I161318765","display_name":"University of California, Los Angeles","ror":"https://ror.org/046rm7j60","country_code":"US","type":"education","lineage":["https://openalex.org/I161318765"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Judith S. Currier","raw_affiliation_strings":["Department of Medicine, School of Medicine, University of California, Los Angeles"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, School of Medicine, University of California, Los Angeles","institution_ids":["https://openalex.org/I161318765"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026533400","display_name":"Robert J. Ryan","orcid":"https://orcid.org/0000-0001-6505-2694","observed_orcids":["https://orcid.org/0000-0001-6505-2694"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert Ryan","raw_affiliation_strings":["Tibotec Inc, Titusville, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tibotec Inc, Titusville, New Jersey","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040749778","display_name":"Ron Falcon","orcid":"https://orcid.org/0000-0002-5924-8110","observed_orcids":["https://orcid.org/0000-0002-5924-8110"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ron Falcon","raw_affiliation_strings":["Clinical Affairs, Tibotec Therapeutics, Titusville, New Jersey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clinical Affairs, Tibotec Therapeutics, Titusville, New Jersey","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032988057","display_name":"Joseph M. Mrus","orcid":"https://orcid.org/0000-0002-7867-0181","observed_orcids":["https://orcid.org/0000-0002-7867-0181"]},"institutions":[{"id":"https://openalex.org/I149251103","display_name":"Thomas Jefferson University","ror":"https://ror.org/00ysqcn41","country_code":"US","type":"education","lineage":["https://openalex.org/I149251103"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Mrus","raw_affiliation_strings":["Department of Medicine, Division of Infectious Diseases, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Division of Infectious Diseases, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I149251103"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112871338","display_name":"Kathleen Squires","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kathleen Squires","raw_affiliation_strings":["Garcia Family Health Group, Harlingen, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Garcia Family Health Group, Harlingen, Texas","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5103094377"],"corresponding_institution_ids":["https://openalex.org/I1285301757"],"apc_list":{"value":3160,"currency":"USD","value_usd":3160},"apc_paid":null,"fwci":0.6595,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.68358036,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"104","issue":"7-8","first_page":"366","last_page":"376"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9945999979972839,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/darunavir","display_name":"darunavir","score":0.8889999985694885},{"id":"https://openalex.org/keywords/ritonavir","display_name":"ritonavir","score":1.0},{"id":"https://openalex.org/keywords/hiv-1","display_name":"HIV-1","score":0.722000002861023},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.8159999847412109},{"id":"https://openalex.org/keywords/racial-disparities","display_name":"racial disparities","score":0.8190000057220459},{"id":"https://openalex.org/keywords/sex-differences","display_name":"sex differences","score":0.6520000100135803},{"id":"https://openalex.org/keywords/virological-response","display_name":"virological response","score":0.8220000267028809},{"id":"https://openalex.org/keywords/treatment-experienced-patients","display_name":"treatment-experienced patients","score":0.8069999814033508},{"id":"https://openalex.org/keywords/black-patients","display_name":"Black patients","score":0.6589999794960022},{"id":"https://openalex.org/keywords/hispanic-patients","display_name":"Hispanic patients","score":0.6890000104904175},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.6880000233650208},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.7480000257492065},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.5989999771118164}],"concepts":[{"id":"https://openalex.org/C2779182219","wikidata":"https://www.wikidata.org/wiki/Q3765251","display_name":"Darunavir","level":5,"score":0.9018254280090332},{"id":"https://openalex.org/C2779298103","wikidata":"https://www.wikidata.org/wiki/Q422618","display_name":"Ritonavir","level":5,"score":0.8281617164611816},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8117902874946594},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6729966998100281},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.6081523299217224},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5010876655578613},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.42399364709854126},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.41727566719055176},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23781615495681763},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.18159335851669312},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.1561187505722046},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.11866626143455505},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069454","descriptor_name":"Darunavir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002170","descriptor_name":"Canada","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011647","descriptor_name":"Puerto Rico","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000208","qualifier_name":"ethnology","is_major_topic":true},{"descriptor_ui":"D015999","descriptor_name":"Multivariate Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017320","descriptor_name":"HIV Protease Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D019438","descriptor_name":"Ritonavir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1016/s0027-9684(15)30179-6","doi":"https://doi.org/10.1016/s0027-9684(15)30179-6","is_oa":false,"landing_page_url":"https://doi.org/10.1016/s0027-9684(15)30179-6","pdf_url":null,"source":{"id":"https://openalex.org/S4210222641","display_name":"Journal of the National Medical Association","issn_l":"0027-9684","issn":["0027-9684","1943-4693"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Medical Association","raw_type":"journal-article"},{"id":"pmid:23092052","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23092052","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Medical Association","raw_type":"Clinical Trial, Phase III"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"},{"score":0.7578999996185303,"display_name":"Reduced inequalities","id":"https://metadata.un.org/sdg/10"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2908551627","display_name":"Optimizing Antiretroviral Therapy in HIV ","funder_award_id":"K24AI056933","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":5,"referenced_works":["https://openalex.org/W1521249888","https://openalex.org/W1567152437","https://openalex.org/W1969089620","https://openalex.org/W2112936116","https://openalex.org/W2416960755"],"related_works":["https://openalex.org/W2005214630","https://openalex.org/W1989932163","https://openalex.org/W2759676278","https://openalex.org/W7096821804","https://openalex.org/W4412467682","https://openalex.org/W2092153061","https://openalex.org/W2604176048","https://openalex.org/W2094521579","https://openalex.org/W2462928586","https://openalex.org/W2052412767"],"abstract_inverted_index":null,"counts_by_year":[{"year":2020,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}